Primary biliary cholangitis in Thai woman: A case report
Keywords:
Primary biliary cholangitis, anti-mitochondrial antibodyAbstract
Primary biliary cholangitis or primary biliary cirrhosis (PBC) is a chronic, slowly progressive, autoimmune, cholestatic liver disease. It is globally considered a rare disease. Herein, we presented a 55-year-old Thai woman who gradually developed fatigue and generalized pruritis without fever for four months. Her physical examination revealed only pallor and jaundice, no liver stigmata, and no hepatosplenomegaly; her blood tests showed: Hb 8.1 g/dL, WBC 12,180/mm3, platelet 143,000/mm3, albumin 2.2 g/dL, globulin 4.0 g/dL, AST 164 U/L, ALT 102 U/L, alkaline phosphatase 384 U/L, total bilirubin 2.8 mg/dL, direct bilirubin 1.3 mg/dL, HBV, HCV and HIVnegative, ferritin 39.9 ng/ml, copper 125 ug/dL, ceruloplasmin 0.27 g/L, urine copper < 1 ug/g creatinine, antismooth muscle antibody-negative, anti-mitochondrial antibody-positive 1:1,600, ANA-positive, homogeneous pattern 1:80, centromere pattern 1:1,280, anti-cytoplasmic antibody-positive 1:1,280, alpha fetoprotein 3.16 ng/ml, creatinine 0.55 mg%, and normal coagulogram. Ultrasonography and the computerized tomography of the upper abdomen showed nodularity and heterogeneous parenchymal disease of the liver, no intrahepatic bile duct dilatation, and slight splenomegaly, compatible with cirrhosis. Esophagogastroduodenoscopy showed acute esophageal variceal bleeding that was successfully treated with rubber band ligation. The diagnosis of PBC was concluded and she was treated with ursodeoxycholic acid and propranolol. Within 6 months, her clinical symptoms as well as transaminitis partially improved.
Downloads
References
Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol 2015;7:926-41. https://doi.org/10.4254/wjh.v7.i7.926
Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet 2015;386:1565-75.
https://doi.org/10.1016/S0140-6736(15)00154-3
Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev 2014;13:441-4.
https://doi.org/10.1016/j.autrev.2014.01.041
Nguyen DL, Juran BD, Lazaridis KN. Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol 2010;24: 647-54. https://doi.org/10.1016/j.bpg.2010.07.006
Pandit S, Samant H. Primary biliary cholangitis (primary biliary cirrhosis). In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2018 [cited 2018 Sep 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459209/.
Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis 2014;34:265-72. https://doi.org/10.1055/s-0034-1383726
Chainuvati T, Viranuvatti V, Damrongsak C, Hitanant S, Chearanai O. Primary biliary cirrhosis report of 3 cases in Thailand. J Med Assoc Thai 1973;56:130-9.
Kim KA, Jeong SH. The diagnosis and treatment of primary biliary cirrhosis. Korean J Hepatol 2011;17:173-9. https://doi.org/10.3350/kjhep.2011.17.3.173
Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:85-91. https://doi.org/10.3238/arztebl.2013.0085
Poupon R. Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation. Hepatology 2015;61:2080-90. https://doi.org/10.1002/hep.27715
Longo M, Crosignani A, Battezzati PM, Squarcia GC, Invernizzi P, Zuin M, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002;51:265-9.
https://doi.org/10.1136/gut.51.2.265
Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 2015;48:192-7.
https://doi.org/10.1007/s12016-014-8427-x
Tanaka A, Miyakawa H, Luketic VA, Kaplan M, Storch WB, Gershwin ME. The diagnostic value of antimitochondrial antibodies, especially in primary biliary cirrhosis. Cell Mol Biol (Noisy -le-grand) 2002;48:295-9.
Zuber MA, Recktenwald C. Clinical correlation of antimitochondrial antibodies. Eur J Med Res 2003;8: 61-70.
Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver Int 2008;28:233-9.
https://doi.org/10.1111/j.1478-3231.2007.01651.x
Satoh M, Vazquez-Del Mercado M, Chan EK. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol 2009;19:219-28.https://doi.org/10.3109/s10165-009-0155-3
Liberal R, Grant CR, Sakkas L, Bizzaro N, Bogdanos DP. Diagnostic and clinical significance of anticentromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 2013;37:572-85.
https://doi.org/10.1016/j.clinre.2013.04.005
Suraweera D, Rahal H, Jimenez M, Viramontes M, Choi G, Saab S. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review. Liver Int 2017;37:1877-86.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.